Supernus Pharmaceuticals
SUPN
#4182
Rank
HK$20.38 B
Marketcap
HK$355.60
Share price
1.29%
Change (1 day)
23.54%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: HK$20.38 Billion

As of December 2025 Supernus Pharmaceuticals has a market cap of HK$20.38 Billion. This makes Supernus Pharmaceuticals the world's 4182th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$20.38 B27.93%
2024HK$15.93 B29.08%
2023HK$12.34 B-18.04%
2022HK$15.06 B24.59%
2021HK$12.09 B17.27%
2020HK$10.31 B6.26%
2019HK$9.70 B-28.69%
2018HK$13.60 B-14.73%
2017HK$15.96 B64.54%
2016HK$9.69 B90.02%
2015HK$5.10 B84.51%
2014HK$2.76 B18.35%
2013HK$2.33 B37.37%
2012HK$1.70 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Supernus Pharmaceuticals was reported to be:

HK$20.38 Billion
by Nasdaq info icon info icon
HK$20.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
HK$11.67 B-42.73%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
HK$172.27 B 744.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.050 T 34,478.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$826.44 B 3,953.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.694 T 8,211.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.787 T 18,474.28%๐Ÿ‡บ๐Ÿ‡ธ USA